Your browser doesn't support javascript.
loading
Interferon-associated retinopathy in a patient with metastatic melanoma / Retinopatia relacionada ao interferon em paciente com melanoma metastático
Borrego-Sanz, Lara; Sáenz-Francés, Federico; Fernández-Tresguerres, M. Fernanda; Jiménez-Santos, Maria; Donate-López, Juan.
  • Borrego-Sanz, Lara; Hospital Clínico San Carlos. Instituto de Investigación Sanitaria. Department of Ophthalmology. Madrid. ES
  • Sáenz-Francés, Federico; Hospital Clínico San Carlos. Instituto de Investigación Sanitaria. Department of Ophthalmology. Madrid. ES
  • Fernández-Tresguerres, M. Fernanda; Hospital Clínico San Carlos. Instituto de Investigación Sanitaria. Department of Ophthalmology. Madrid. ES
  • Jiménez-Santos, Maria; Hospital Clínico San Carlos. Instituto de Investigación Sanitaria. Department of Ophthalmology. Madrid. ES
  • Donate-López, Juan; Hospital Clínico San Carlos. Instituto de Investigación Sanitaria. Department of Ophthalmology. Madrid. ES
Arq. bras. oftalmol ; 77(5): 321-323, Sep-Oct/2014. graf
Article in English | LILACS | ID: lil-730378
ABSTRACT
We present the unusual case of a 35 year-old woman with stage IV melanoma and widespread metastases, who was undergoing treatment with interferon alpha-2b and who presented with interferon-associated retinopathy. The patient, who had been taking interferon treatment for three months, complained of a sudden loss of visual acuity in the left eye. An ocular examination revealed multiple cotton wool spots along the retina and macular involvement. Interferon treatment was suspended. Although rare, retinopathy represents a potentially serious adverse effect of interferon treatment. Although normally patients are asymptomatic, complications derived of its use may arise, which can lead to significant visual impairment. We therefore suggest that before initiating treatment with this drug, patients should be informed of its potential ocular risks, and that regular eye examinations are conducted along with the treatment.
RESUMO
Apresentamos o caso de uma mulher de 35 anos com melanoma em estágio IV e metástases generalizadas tratados com interferon alpha-2b, que proporcionou uma retinopatia associada ao interferon. Mulher de 35 anos de idade tratados com interferon durante os últimos três meses apresentou uma perda súbita da acuidade visual no olho esquerdo. Exame ocular revelou vários pontos de algodão ao longo da retina e mácula. Tratamento com interferon foi parado. Retinopatia associada ao uso de interferon está entre os possíveis efeitos colaterais, embora rara, não deve ser subestimada. Embora geralmente assintomática, complicações decorrentes de seu uso podem levar à perda visual significativa. Consideramos, portanto, que antes de iniciar o tratamento com este medicamento, os pacientes devem ser informados sobre os riscos potenciais e os exames oftalmológicos são recomendados durante cada tratamento.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Retinal Diseases / Interferon-alpha / Melanoma Type of study: Risk factors Limits: Humans Language: English Journal: Arq. bras. oftalmol Journal subject: Ophthalmology Year: 2014 Type: Article Affiliation country: Spain Institution/Affiliation country: Hospital Clínico San Carlos/ES

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Retinal Diseases / Interferon-alpha / Melanoma Type of study: Risk factors Limits: Humans Language: English Journal: Arq. bras. oftalmol Journal subject: Ophthalmology Year: 2014 Type: Article Affiliation country: Spain Institution/Affiliation country: Hospital Clínico San Carlos/ES